IRadimed Corp expected to post earnings of 28  cents a share - Earnings Preview

IRADIMED

25/04/2023 13:32

* IRadimed Corp  IRMD.OQ   IRMD.O  is expected to show a
rise in
quarterly revenue when it reports  results on April 27
(estimated). 
    * The Winter Springs Florida-based  company is expected to
report 
a 19.9% increase in revenue to $14.767 million from $12.31
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on
February 2 2023, for the period ended March 31, was for revenue
between $14.60 million and $14.90 million.
    * ​Refinitiv's mean analyst estimate for IRadimed Corp is
for
earnings of 28 cents per share. The company's EPS guidance on
February 2 2023, for the period ended March 31, was between
$0.26 and $0.28 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for IRadimed
Corp is
$50​, above​ its last closing price of $41.14. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.30        0.30       0.32      Beat    6.7
 Sep. 30 2022  0.25        0.25       0.29      Beat    18.4
 Jun. 30 2022  0.24        0.24       0.26      Beat    10.6​
 Mar. 31 2022  0.21        0.21       0.22      Beat    7.3
 ​​Dec.        0.21        0.21       0.33      Beat    57.1
 31 2021                                                
 Sep. 30 2021  0.17        0.17       0.23      Beat    35.3​
 Jun. 30 2021  0.09        0.10       0.14      Beat    47.4
 Mar. 31 2021  0.10        0.10       0.13      Beat    30
 This summary was machine generated April 25 at 12:32 GMT.  All
figures in US dollars  unless otherwise stated